CIG-C Financial Statements & Analysis
Complete financial statements for CIG-C including income statement, balance sheet, and cash flow statement. Analyze CIG-C's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
7.4% ↑
Net Income
-31.2% ↓
Gross Margin
-13.9% ↓
Operating Margin
-21.3% ↓
Balance Sheet
Current Ratio
15.8% ↑
Debt to Equity
49.9% ↓
Asset Turnover
-4.3% ↓
Cash Flow
Operating Cash Flow
-27.3% ↓
Net Cash Flow
-39.7% ↓
Free Cash Flow
-27.7% ↓
Cash Flow to Debt
-53.5% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 39.82B | 42.75B | 7.4% | |
| Gross Profit | 7.83B | 7.24B | 7.6% | |
| Operating Income | 7.49B | 6.33B | 15.5% | |
| Net Income | 7.12B | 4.90B | 31.2% | |
| EPS | 2.49 | 1.70 | 31.7% | |
| EBITDA | 11.74B | 8.71B | 25.9% | |
| Gross Margin | 19.66% | 16.93% | 13.9% | |
| Operating Margin | 18.81% | 14.80% | 21.3% | |
| Net Income Margin | 17.87% | 11.45% | 35.9% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 42.75B | 39.82B | 36.85B | — | — |
| Gross Profit | 7.24B | 7.83B | 8.38B | — | — |
| Operating Income | 6.33B | 7.49B | 6.21B | — | — |
| Net Income | 4.90B | 7.12B | 5.76B | — | — |
| EPS | 1.70 | 2.49 | 2.01 | — | — |
| EBITDA | 8.71B | 11.74B | 9.15B | — | — |
| Gross Margin | 16.93% | 19.66% | 22.75% | — | — |
| Operating Margin | 14.80% | 18.81% | 16.86% | — | — |
| Net Income Margin | 11.45% | 17.87% | 15.64% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into CIG-C's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics